Anxiety and depression in small fiber neuropathy

Autor:	Aysun Damci, Koen R. J. Schruers, Carsten Leue, Catharina G. Faber, Janneke G. J. Hoeijmakers
Přispěvatelé:	RS: MHeNs - R3 - Neuroscience, Klinische Neurowetenschappen, Psychiatry 1, RS: MHeNs - R2 - Mental Health, Psychiatrie & Neuropsychologie, MUMC+: MA Med Staf Spec Psychiatrie (9), RS: MHeNs - R1 - Cognitive Neuropsychiatry and Clinical Neuroscience, MUMC+: MA Med Staf Spec Neurologie (9)
Jazyk:	angličtina
Rok vydání:	2022
Předmět:	neuropathic pain GENDER-DIFFERENCES small fiber neuropathy IMPACT DISORDERS General Neuroscience DIAGNOSTIC-CRITERIA association HOSPITAL ANXIETY anxiety QUALITY-OF-LIFE depression Neurology (clinical) HEALTH MENTAL-ILLNESS COMORBIDITY CHRONIC PAIN
Zdroj:	Journal of the Peripheral Nervous System, 27(4), 291-301. Wiley
ISSN:	1529-8027 1085-9489
Popis:	Psychiatric comorbidity is common in patients with chronic pain. In peripheral neuropathic pain, particularly anxiety and mood disorders are frequently present and associated with a high level of catastrophizing. Small fiber neuropathy (SFN) is a peripheral neuropathy dominated by pain. This study aimed to investigate the prevalence of and factors associated with anxiety and depressive symptoms in SFN. All consecutive patients diagnosed with SFN at Maastricht University Medical Center+, between September 2016 and October 2021, were included (n = 1310). Data on demographics, medical history, diagnostic tests, and questionnaires about pain, SFN-specific symptoms, and mental health were collected once. The Hospital Anxiety and Depression Scale (HADS) was used to measure anxiety and depression and the Pain Catastrophizing Scale (PCS) to measure the degree of catastrophizing. One-third of the patients had an abnormal HADS score (>= 11) on the subscales anxiety and/or depression (26.5% anxiety and 23.0% depression) indicating clinical relevance. Regression analysis showed that higher pain intensity, catastrophizing, and more SFN-related complaints were significantly associated with an abnormal HADS-score. In conclusion, the prevalence of reported anxiety or depressive symptoms in SFN is 36.3%. A multidisciplinary approach, not only focusing on pain relief, is therefore essential for the treatment of SFN.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90896ef953d09249f9f0ab9a9504e29b https://cris.maastrichtuniversity.nl/en/publications/69f174e4-e256-46a9-a366-91bed4a26730 Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.